Effects of Plasmalogen on Patients with Mild Cognitive Impairment: A Randomized,Placebo-Controlled Trial in Japan
Effects of Plasmalogen on Patients with Moderate-to-Severe Alzheimer’s disease and Blood Plasmalogen Changes: A Multi-Center,Open-Label Study
Improvement of Blood Plasmalogens and Clinical Syptoms in Parkinson’s Disease by Oral Administration of Ether Phospholipids: A Preliminary Report